CH3: Primary Care Flashcards
what is “primary prevention”
delivery of healthcare services that focuses on PREVENTING disease from occurring
examples: immunizations, health promotion counseling
what is “secondary prevention”
delivery of healthcare services that focuses on EARLY DETECTION of disease states as well as interventions that will LIMIT the severity and morbidity
examples: identification of risk factors, screening tests, counseling and education
what is “tertiary prevention”
delivery of healthcare services that focuses on RESTORING OPTIMAL FUNCTION, improving health status, and limiting long-term disability AFTER the diagnosis of disease
examples: treatment of disease, rehab
what is “health screening”
laboratory or other tests conducted on asymptomatic individuals routinely for the early detection of health problems
health screening is an example of _______ prevention
secondary prevention
colorectal cancer screening ages for average risk, recommendations per the ACS
adults 45yo and older should undergo regular screening with either a high-sensitivity stool-based test or a structural (visual) exam (e.g., colonoscopy)
adults in good health with life expectancy >10 years should continue screening through age 75yo
for colorectal cancer screening – more frequent testing and starting at a younger age is recommended for those with risk factors, including:
- inflammatory bowel disease (IBD)
- personal or family history of colon polyps or CRC
- known or suspected Lynch Syndrome (hereditary nonpolyposis colon cancer)
Lynch Syndrome, aka….
hereditary nonpolyposis colon cancer
available stool-based tests for colorectal cancer screening (3)
Fecal Occult Blood Tests (FOBTs)
- guaiac fecal occult blood test (gFOBT) (annual)
- fecal immunochemical test (FIT) (annual, superior to guaiac based FOBT)
Stool DNA-Fecal Immunochemical Test
3. stool DNA test (Q3 years)
What is the guaiac fecal occult blood test for CRC screening
multiple-stool sample collected at-home that detects hidden blood in the stool
recommended to complete ANNUALLY for screening
What is the stool DNA test for CRC screening
single-sample collected at-home that detects (1) DNA from cancer, (2) polyp cells, or (3) blood in stool.
recommended to complete Q3 YEARS for screening
What is the fecal immunochemical test for CRC screening
single-sample, collected at home, tests for blood in stool. more sensitive than gFOBT
recommended to complete ANNUALLY for screening
available structural (visual) screening tests for CRC (3)
- colonoscopy (generally Q10 years)
- flexible sigmoidoscopy (generally Q5 years)
- CT colonography (generally Q5 years)
Clinical Breast Examination (CBE) recommendations for breast cancer screening, per ACS
NOT recommended among average-risk females at any age
Average risk = no personal history of breast cancer, no suspected or confirmed genetic mutation known to increase breast cancer risk, and no previous radiation therapy to the chest
Clinical Breast Examination (CBE) recommendations for breast cancer screening, per ACOG
Offer every 1-3 years for pts age 25-39yo, and annually after 40yo
Offer in the context of shared, informed decision making approach that recognizes there is uncertainty of any additional benefit and harms of CBE in folks who are already getting on-schedule screening mammograms
Clinical Breast Examination (CBE) recommendations for breast cancer screening, per USPSTF
Insufficient evidence to assess the balance of benefits and harms of CBE if the pt is also being screened with mammograms (Grade I)
Mammogram recommendations for breast cancer screening, per ACS
Yearly beginning at age 45yo for average risk pts. Offer to start between ages 40-45yo.
Can transition to every other year (biennially) after age 55yo, or can continue annually, per patient preference.
No definitive age at which to discontinue screening - base shared-decision making on patient’s health status and whether they would elect for breast cancer treatment if diagnosed
Mammogram recommendations for breast cancer screening, per ACOG
Offer to start anytime between ages 40-49yo. No later than 50yo.
Both annual and biennial (every other year) intervals are acceptable, per patient preference
No definitive age at which to discontinue screening - base shared-decision making on patient’s health status and whether they would elect for breast cancer treatment if diagnosed
Mammogram recommendations for breast cancer screening, per USPSTF
Biennial (every other year) from ages 50-74yo (Grade B evidence).
Insufficient evidence to assess the balance of benefits and harms in patients 75yo and older (Grade I)
Breast self awareness (BSA) recommendations for breast cancer screening, per ACS and ACOG
Educate females 20yo and older about BSA and when to seek further evaluation. Encourage patient to know the normal appearance and feel of their own breast so they can be alert to any changes.
No systematic or regular technique or self-examination
Pap test recommendations for cervical cancer screening <21yo, per ACS
<21yo, screening is not recommended
Pap test recommendations for cervical cancer screening <21yo, per ACOG
<21yo, screening is not recommended EXCEPT if they have HIV, begin screening within 1 year after starts to have sexual activity and no later than age 21yo
Pap test recommendations for cervical cancer screening <21yo, per USPSTF
<21yo, screening is not recommended
Pap test recommendations for cervical cancer screening 21-29yo, per ACS
cytology alone Q3 years